NINTAB ID 150

Nintabid 150 Soft Gelatin Capsule is indicated for the management of idiopathic pulmonary fibrosis and non-small cell lung cancer. This medication functions by targeting specific biological pathways associated with the development and advancement of these conditions, aiding in the inhibition or deceleration of cancer cell proliferation. It is generally advised to administer Nintabid 150 alongside food for optimal absorption, and maintaining a consistent daily schedule for taking the capsule can enhance its effectiveness. Your healthcare provider will determine the appropriate dosage and the frequency of administration based on your individual treatment needs, which may be subject to change over time. It is essential to adhere strictly to the prescribed regimen, as incorrect usage or exceeding the recommended dose may lead to serious adverse effects. While the benefits of the treatment may take several weeks or even months to manifest, it is critical not to discontinue the medication without consulting your physician first. Diarrhea is a notably frequent side effect associated with this medication; thus, ensuring adequate hydration is recommended, and you should inform your healthcare provider if this symptom persists. Other potential side effects include nausea, stomach discomfort, vomiting, irregular liver function tests, decreased appetite, headaches, weight reduction, and elevated blood pressure. Regular blood tests may be requested by your doctor to monitor liver health during your treatment. Prior to initiating therapy with this capsule, it is important to discuss any history of bleeding disorders, liver or kidney issues, or concurrent use of infection-related medications with your healthcare provider, as interactions can occur. The medication is not advised for use in pregnant or breastfeeding individuals, and both genders should utilize reliable birth control methods to prevent unintended pregnancies during treatment.